Fw: Novartis makes TWO swine flu vaccines–one with squalene, one w

From: Andrew Johnson

Date: 2009-10-20 19:00:14

#ygrps-yiv-791608081 DIV { MARGIN:0px;}   From: Mark Crispin Miller mailto:mark.miller%40nyu.edu>mark.miller@nyu.edu> Date: October 19, 2009 7:23:42 AM PDT To: mailto:newsfromunderground%40googlegroups.com>newsfromunderground@googlegroups.com Subject: [MCM] Novartis makes TWO swine flu vaccines–one with squalene, one without Reply- mailto:newsfromunderground%2Bowner%40googlegroups.com>newsfromunderground+…   It turns out that Novartis makes two swine flu vaccines–one with MF59, its own squalene adjuvant, and one without. And it’s the one without the adjuvant that’s been approved for use here by the CDC.   The other version, with squalene, is being shipped abroad for use on other populations; so there should be a push to spread the word abroad, so that other governments will just say no.   This point–that Novartis makes two versions of swine flu vaccine– is only one example of how thoroughly confusing the whole vaccine situation really is. Meryl Nass writes:   “There are several versions of H1N1 vaccines, just to confuse everyone.   “Here goes: some is live, some killed. Some is made in eggs, some is made in tissue culture using dog tumor (I think kidney tumor) cells. None in the US has either aluminum adjuvants or squalene adjuvants. But either or both may be part of vaccines used overseas. There are 5 different manufacturers for the US market and more for other countries. Most in the US will have 25 mcg mercury per dose, but some will have very little mercury, as it is intended for pregnant women and kids under 6 years.”   That this is such a mare’s nest makes it all the more important that we get clear, thorough coverage from the press. (The Times ought to have pointed out that there is squalene in the swine flu vaccine that Novartis makes for use in other countries.) Since we’re not getting such reporting from the press, we have to do the best we can with what we have.   So I will shortly send out something about Novartis’s use of tumor cells to make their H1N1 vaccine–a practice that may well be dangerous (and yet the only doctors who have sounded some alarm about it are in Germany).   MCM       –~–~———~–~—-~————~——-~–~—-~You received this message because you are subscribed to Mark Crispin Miller’s “News From Underground” newsgroup. To unsubscribe, send a blank email to newsfromunderground-…   OR go to groups.google.com/gr… and click on the “Unsubscribe or change membership” link in the yellow bar at the top of the page, then click the “Unsubscribe” button on the next page.   For more News From Underground, visit markcrispinmiller.co… -~———-~—-~—-~—-~——~—-~——~–~—       [Non-text portions of this message have been removed]     This email was cleaned by emailStripper, available for free from www.papercut.biz/ema… No virus found in this incoming message.Checked by AVG – www.avg.comVersion: 8.5.423 / Virus Database: 270.14.20/2441 – Release Date: 10/20/09 10:43:00

Related articles...

Comments are closed.